Patent ID: 7176194
Filing Date: 2007-02-13
Classification: A61P,C07D,Y10S

Abstract:
1. A compound of the formula I, wherein: R1, R2, R3, R4, R5, and R6, independently of one another, are chosen from: wherein at least one carbon atom of the alkyl radical is optionally replaced by a radical chosen from: —S(O) m — (where m=0–2), —O—, —(C═O)—, —(C═S)—, —CH═CH—, —C≡C—, —N((C 1 –C 6 )-alkyl)—, —N(phenyl), —N((C 1 –C 6 )-alkyl-phenyl)—, —N(CO—(CH 2 ) 1-10 —COOH)— and —NH—; or R7 represents F, Cl, Br, I, CF (LAG) is an acyclic trialkylammonium radical, a mono-, di- or tricyclic trialkylammonium radical, an acyclic trialkylammoniumalkyl radical, a mono-, di- or tricyclic trialkylammoniumalkyl radical, —O—(SO wherein q=1–5 and wherein R8, R9, R10 and R11, independently of one another, are chosen from: H, (C and wherein at least one of the radicals R1 to R6 must have the meaning: (C wherein the mono-, di- or tricyclic trialkylammonium radical is chosen from: wherein one or more CH wherein the mono-, di- or tricyclic trialkylammoniumalkyl radical is chosen from: a radical chosen from: wherein each of n, m and p, independently of one another, represent a number between 0–10; and wherein one or more CH or a pharmaceutically acceptable salt thereof, in any stereoisomeric form, or a mixture of any such compounds in any ratio.